Form 15-12G Columbia Financial, Inc.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
Certification and Notice of Termination of Registration
under Section 12(g) of the Securities Exchange Act of 1934
or Suspension of Duty to File Reports under Sections 13 and 15(d)
of the Securities Exchange Act of 1934
Commission File No. 001-38456
COLUMBIA FINANCIAL, INC.
(Exact name of registrant as specified in its charter)
19-01 Route 208 North, Fair Lawn, New Jersey 07410
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Common stock, par value $0.01 per share
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
| Rule 12g-4(a)(1) |
☒ | |
| Rule 12g-4(a)(2) |
☐ | |
| Rule 12h-3(b)(1)(i) |
☒ | |
| Rule 12h-3(b)(1)(ii) |
☐ | |
| Rule 15d-6 |
☐ | |
| Rule 15d-22(b) |
☐ |
Approximate number of holders of record as of the certification or notice date: None
Pursuant to the requirements of the Securities Exchange Act of 1934, Columbia Financial, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
| Date: July 20, 2026 | By: | /s/ Dennis E. Gibney | ||||
| Dennis E. Gibney | ||||||
| First Senior Executive Vice President, | ||||||
| Chief Banking Officer | ||||||
| Columbia Financial, Inc., a Maryland corporation | ||||||
| (as successor to Columbia Financial, Inc., a Delaware corporation) |
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tilley Harley-Davidson Hosts Christmas in July Toys for Tots Fundraiser Featuring Motorcycle Stunt Shows, Family Activities, And More!
- Verisign Announces Delegation of .Web
- Nona Biosciences Enters Research Collaboration with the Medical University of Vienna to Advance Fully Human Antibody Development for Infectious Diseases
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share